DARPA has advanced four companies to Stage C, the final phase of its Quantum Benchmarking Initiative. IonQ disclosed a Stage C agreement valued at up to $300 million to develop and test utility-scale quantum systems through 2029.
What's happening
- DARPA selected Atom Computing, Diraq, IBM, and IonQ for Stage C, each pursuing different qubit technologies including neutral atoms, silicon CMOS spins, superconducting processors, and trapped ions.
- IonQ signed a Stage C agreement worth up to $300 million running through 2029, under which DARPA's independent team will test multiple generations of IonQ's Superion quantum systems.
- IBM plans to deliver its first fault-tolerant quantum computer, IBM Quantum Starling, in 2029 as part of Stage C testing.
- Microsoft and PsiQuantum also entered Stage C after completing a pilot program, bringing total Stage C participants to six companies.
Why it matters
- The Quantum Benchmarking Initiative aims to determine whether any quantum approach can reach utility scale, defined as computational value exceeding cost, by 2033.
- Independent verification by DARPA's evaluation team provides the first major government assessment of competing quantum computing architectures' credibility for near-term utility.
- Stage C's shift from plans to proof-of-concept tests hardware development against technical roadmaps, identifying which approaches can sustain performance claims at scale.
- The initiative's non-competitive structure assesses all approaches on merit rather than picking winners, reducing risk that a single technical path dominates defense quantum capability.
Going deeper
- QBI began in mid-2024, with more than 20 companies evaluated across three stages: Stage A submitted concepts, Stage B reviewed development plans and risk mitigation, Stage C verifies hardware builds to specification.
- DARPA released a new Stage A solicitation earlier in 2026 and expects to select additional companies, indicating the initiative will continue expanding the vendor pool.
Financial impact
- IonQ's $300 million Stage C agreement flows as government support contingent on future appropriations and DARPA funding actions through 2029, recognized as contract revenue over the period of performance.
- The deal structure ties funding beyond initial obligation to annual congressional appropriations, creating revenue visibility through 2029 dependent on defense spending priorities.
The fine print
- IonQ's $300 million represents ceiling value, with actual funding dependent on future appropriations and DARPA funding decisions through 2029.
- Stage C focuses on verification and validation rather than development completion, meaning systems must perform according to technical roadmaps but may not reach production deployment.
